Yearly Archives: 2017
Press Releases
CRF Health’s Trial Max Touch® Solution Selected for Landmark Global Oncology Study
CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry announced that its TrialMax Touch® solution...
Press Releases
Medeon Biodesign Announces Successful Clinical Use of AbClose™ Laparoscopic Port Site Closure Device in the USA
Medeon Biodesign, Inc., a publicly traded medical device company headquartered in Taipei, is pleased to announce that its innovative laparoscopic port site closure device,...
News
For Treatment of Dry Eye Syndrome Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program
Aurinia Pharmaceuticals Inc. announced plans to expand its voclosoprin renal franchise to include focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD). Additionally, Aurinia...
Press Releases
Latifa Hospital for Women and Children Selects Vocera to Improve Patient Care
Vocera Communications, Inc. , a recognized leader in clinical communication and workflow solutions, announced that Latifa Hospital for Women and Children in Dubai, United...
Industry Reports
Johnson & Johnson Medical GmbH to Acquire Surgical Process Institute
Johnson & Johnson Medical GmbH today announced a definitive agreement to acquire German software company, Surgical Process Institute (SPI), a leading specialist for the...
Press Releases
UPM Raflatac introduces new labeling solutions for medical device and healthcare applications in CPhI
UPM Raflatac will be present at the CPhl Innopack exhibition on 24-26 October 2017 in Frankfurt, Germany. Visitors will have the opportunity to discuss...
News
Chi-Med and AstraZeneca’s Savolitinib Shows Encouraging Clinical Activity in Second-Line EGFR Mutation-Positive Lung Cancer with MET-Amplification
Hutchison China MediTech Limited and AstraZeneca PLC presented preliminary safety and clinical activity data of savolitinib when given in combination with either Tagrisso® (osimertinib) or Iressa®...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read